ACHE and early-onset autosomal dominant Alzheimer disease: In a randomized trial by Consolim-Colombo et al. Galantamine, a centrally acting acetylcholine esterase inhibitor clinically used to prevent progression of Alzheimer’s disease and known to activate CAP, was administered to patients with metabolic syndrome (Consolim-Colombo et al., 2017).